Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Buy and Sell Signals, and Other Market Perspectives -- Ignore unavailable to you. Want to Upgrade?

To: Hawkmoon who wrote (143447)	4/3/2020 6:02:22 PM
From: GROUND ZERO™	Read Replies (1) \| Respond to of 222311

No, I don't think anyone would intentionally design a study poorly... experimental design is a highly sophisticated and disciplined process within the field of experimental research either medical or any disciplined scientific field, experimental design is an entire field of graduate study itself... So often, when researchers are in a hurry to test something, they fail to design the study properly and end up with crap results... This is what I suspect happened in this study, and only because in real life it was highly successful and yet in their trials it failed... If it work here, then it works everywhere, so why it failed in their study is very likely due to a poorly designed study... if it works, then it works... it can't work with real patients and then not work in a trial, that's just plain illogical... GZ